EPT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.054400E-02
Normal-vs-Stage2
3.688200E-01
Normal-vs-Stage3
4.357200E-01
Normal-vs-Stage4
4.962300E-02
Stage1-vs-Stage2
1.581990E-01
Stage1-vs-Stage3
9.501500E-03
Stage1-vs-Stage4
7.778400E-01
Stage2-vs-Stage3
9.424100E-02
Stage2-vs-Stage4
1.552990E-01
Stage3-vs-Stage4
2.114100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.247400E-01
Normal-vs-AfricanAmerican
1.472610E-01
Normal-vs-Asian
6.541200E-01
Caucasian-vs-AfricanAmerican
3.709400E-01
Caucasian-vs-Asian
2.097400E-01
AfricanAmerican-vs-Asian
1.316360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.479800E-01
Normal-vs-Female
3.219800E-01
Male-vs-Female
6.130000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.588000E-02
Normal-vs-Age(41-60Yrs)
2.444800E-01
Normal-vs-Age(61-80Yrs)
4.051200E-01
Normal-vs-Age(81-100Yrs)
4.418200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.730400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.091600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.948800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.276200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.469400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.832800E-01
Normal-vs-Daily Drinker
4.372000E-01
Normal-vs-Weekly Drinker
6.762200E-01
Normal-vs-Occasional Drinker
8.982200E-03
Normal-vs-Social Drinker
2.498000E-01
Non Drinker-vs-Daily Drinker
8.378000E-01
Non Drinker-vs-Weekly Drinker
5.203600E-01
Non Drinker-vs-Occasional Drinker
6.892400E-02
Non Drinker-vs-Social Drinker
2.286200E-01
Daily Drinker-vs-Weekly Drinker
4.326200E-01
Daily Drinker-vs-Occasional Drinker
1.292440E-01
Daily Drinker-vs-Social Drinker
3.367000E-01
Weekly Drinker-vs-Occasional Drinker
4.512500E-02
Weekly Drinker-vs-Social Drinker
1.199960E-01
Occasional Drinker-vs-Social Drinker
5.822800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.397790E-01
Normal-vs-Grade 2
7.048500E-02
Normal-vs-Grade 3
1.266110E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.610800E-01
Grade 1-vs-Grade 3
8.666400E-01
Grade 1-vs-Grade 4
1.397790E-01
Grade 2-vs-Grade 3
3.551800E-01
Grade 2-vs-Grade 4
7.048500E-02
Grade 3-vs-Grade 4
1.266110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.893400E-01
Normal-vs-NonDiabetic
3.775800E-01
Diabetic-vs-NonDiabetic
4.569000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.623600E-01
Normal-vs-NoPancreatitis
3.957400E-01
Pancreatitis-vs-NoPancreatitis
6.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.086400E-01
Normal-vs-N1
3.526200E-01
N0-vs-N1
3.548600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.576430E-01
Normal-vs-TP53-NonMutant
1.957370E-01
TP53-Mutant-vs-TP53-NonMutant
8.590400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
